STAT-1 and STAT-3: Closely related transcription factors with antagonistic effects on cell proliferation and apoptosis

Current Genomics

Volumn 5, Issue 5, 2004, Pages 453-457

  Latchman, D S ^a   Stephanou, A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; DNA damage; p53; Protein interaction; STAT 1; STAT 3

Indexed keywords

CELL RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN INHIBITOR; PROTEIN P300; PROTEIN P53; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL PROLIFERATION; CELL TYPE; DRUG MECHANISM; DRUG POTENCY; GENETIC TRANSCRIPTION; GROWTH DISORDER; HEART HEMODYNAMICS; HEART VENTRICLE FUNCTION; MODULATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL;

EID: 3042580201     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389202043349066     Document Type: Review

References (41)

1. Ihle, J.N. The Stat family in cytokine signalling. Curr. Opin. Cell Biol. 2001, 13: 211-217.
2. Lim, C.P. and Cao, X. Regulation of Stat3 activation by MEK kinase 1. J. Biol. Chem. 2001, 276: 21004-21011.
3. Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., Zotter, A., Levy, D.E., Muller, M. and Decker, T. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 2001, 20:91-100.
4. O'Shea, J.J., Gadina, M. and Schreiber, R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002, 109 Suppl: S121-31.
5. Yoo, J.Y., Huso, D. L., Nathans, D. and Desiderio, S. Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock. Cell 2002, 108: 331-44.
6. Yasukawa, H., Sasaki, A. and Yoshimura, A. Negative regulation of cytokine signalling pathways. Annu. Rev. Immunol. 2000, 18: 143-64.
7. Krebs, D.L. and Hilton, D.J. SOCS: physiological suppressors of cytokine signalling, J. Cell Sci. 2000, 113: 2813-2819.
8. Greenhalgh, C.J. and Hilton, D.J. Negative regulation of cytokine signaling, J. Leukoc. Biol. 2001, 70: 348-356.
9. Liu, B., Liao, J., Rao, X., Kushner, S.A., Chung, C.D, Chang, D.D. and Shuai, K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 1998, 95: 10626-10631.
10. Chung, C.D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P. and Shuai, K. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997, 278: 1803-1805.
11. Kahyo, T., Nishida, T. and Yasuda, H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 2001, 8: 713-718.
12. Stark, G.R., Kerr, I.A., Williams, B.R., Silverman, R.H. and Schreiber, R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67: 227-264.
13. Durbin, J.E., Hackenmiller, R., Simon, M.C. and Levy, D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84: 443-450.
14. Kaplan, D.H., Shankaran, V., Dighe, A.S., Stoker, E., Aguet, M., Old, L.J. and Schreiber, R.D. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 1998, 95: 7556-7561.
15. Bromberg, F.J. Activation of STAT proteins and growth control. Bioessays 2001, 23: 161-169
16. Kumar, A., Commane, M., Flickinger, T.W., Horvath, C.M and Stark, G.R. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997, 278: 1630-1632.
17. Janjua, S., Stephanou, A. and Latchman, D.S. The C-terminal activation domain of STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death and Differentiation 2002, 9: 1140-1146.
18. Stephanou, A., Brar, B.K., Scarabelli, T., Jonassen, A.K., Yellon, D.M., Marber, M.S., Knight, R.A. and Latchman, D.S. Ischaemia-induced STAT-1 expression and activation plays a critical role in cardiac myocyte apoptosis, J. Biol. Chem. 2000, 275: 10002-10008.
19. Stephanou, A., Scarabelli, T., Brar, B.K., Nakanishi, Y., Matsumura, M., Knight, R.A. and Latchman, D.S. Induction of apoptosis and Fas/FasL expression by ischaemia/reperfusion in cardiac myocytes requires serine 727 of the STAT1 but not tyrosine 701. J. Biol. Chem. 2001, 276: 28340-28347.
20. Stephanou, A., Scarabelli, T., Townsend, P.A., Bell, R., Yellon, D.M., Knight, R.A. and Latchman, D.S. The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischaemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J. 2002, 16: 1841-1843.
21. Lee, C-K., Smith, E., Gimeno, R., Gertner, R. and Levy, D.E. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 2000, 164: 1286-1292.
22. Chin, Y.E., Kitagawa, M., Su, W.C., You, Z.H., Iwamoto, Y. and Fu, X.Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996, 272: 719-722.
23. Ouchi, T., Lee, S.M., Ouchi, M., Aaronson, S.A. and Horvath, C.M. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-γ- target genes. Proc. Natl. Acad. Sci. USA 2000, 97: 5208-5213.
24. Wang, Y., Wu, T.R., Cai, S., Welte, T. and Chin, Y.E. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol. Cell Biol. 2000, 20: 4505-4512.
25. Townsend, P.A., Scarabelli, T.M., Davidson, S.M., Knight, R.A., Latchman, D.S. and Stephanou, A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis, J. Biol. Chem. 2004, 279: 5811-5820
26. Macleod, K.F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995; 8: 935-944.
27. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J. and Livingston, D.M. Binding and modulation of p53 by p300/CBP coactivators. Nature 1997, 387: 823-827.
28. Gu, W. and Roeder, R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90: 595-606.
29. Vousden, K.H. and Lu, X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 8: 594-604.
30. Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T. and Akira, S. STAT3 activation is a critical step in gpl30-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 1996, 93: 3963-3966.
31. Chapman, R.S., Lourenco, P.C., Tonner, E., Flint, DJ., Selbert, S., Takeda, K., Akira, S., Clarke, A.R. and Watson, C.J. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3∴ Genes Dev. 1999, 13: 2604-2616.
32. Garcia, R. and Jove, R. Activation of STAT transcription factors in oncogenic tyrosine kinase signalling J. Biomed. Sci. 1998, 5: 79-85.
33. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C. and Darnell, J.E. Jr. Stat3 as an oncogene. Cell 1999, 98: 295-303.
34. Niu, G., Shain, K.H., Huang, M., Ravi, R., Bedi, A., Dalton, W.S., Jove, R. and Yu, H. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res. 2001, 61: 3276-3280.
35. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J.S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. and Roifman, C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379: 645-648.
36. Ivanov, V.N., Bhoumik, A., Kräsilnikov, M., Raz, R., Owen-Schaub, L.B., Levy, D., Horvath, C.M. and Ronai, Z. Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol. Cell 2001, 7: 517-528.
37. Zhang, J., Yang, J., Roy, S.K., Tininini, S., Hu, J., Bromberg, J.F., Poli, V., Stark, G.R. and Kalvakolanu, D.V. The cell death regulator GRIM- 19 is an inhibitor of signal transducer and activator of transcription 3. Proc. Natl. Acad. Sci. USA 2003, 100: 9342-9347.
38. Nakayama, K., Kim, K.W. and Miyajima, A. A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3. EMBO J. 2002, 21: 6174-6184.
39. Epling-Burnette, P.K., Liu, J.H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.M., Yang-Yen, H.F., Karras, J., Jove, R., Loughran, T.P. Jr. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 2001, 107: 351-362.
40. Ni, Z., Lou, W., Leman, E.S. and Gao, A.C. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res. 2000, 60: 1225-1228
41. Menegazzi, M., Tedeschi, E., Dussin, D., de Prati, A.C., Cavalieri, E., Mariotto, S. and Suzuki, H. Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J. 2001, 15: 1309-1311.